Subcutaneous enoxaparin safely facilitates bedside sustained low-efficiency hemodialysis in hypercoagulopathic Coronavirus disease 2019 patients - proof-of-principle trial / Elke Neumann-Haefelin, Eugen Widmeier, Joachim Bansbach, Kai Kaufmann, Sebastian Heinrich, Gerd Walz, Hartmut Bürkle, Johannes Kalbhenn
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
Alphen aan den Rijn: Wolters Kluwer Health, Inc. ; 2020 Freiburg: Albert-Ludwigs-Universität Freiburg ; 2020 |
| Enthalten in: |
Critical care explorations - 2, 6 (2020), e0155 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Neumann-Haefelin, Elke, 1976- [VerfasserIn] |
|---|
| Links: |
nbn-resolving.de [kostenfrei] |
|---|
| Themen: |
COVID-19 |
|---|
| Umfang: |
1 Online-Ressource (4 Seiten) ; Diagramme |
|---|
| doi: |
10.1097/CCE.0000000000000155 |
|---|---|
| Weitere IDs: |
urn:nbn:de:bsz:25-freidok-1663422 FRUB-opus-166342 |
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
172718212X |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 172718212X | ||
| 003 | DE-627 | ||
| 005 | 20230427022524.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200817s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a urn:nbn:de:bsz:25-freidok-1663422 |2 urn | |
| 024 | 7 | |a 10.1097/CCE.0000000000000155 |2 doi | |
| 024 | 8 | |a FRUB-opus-166342 |q Opus-Nr. | |
| 035 | |a (DE-627)172718212X | ||
| 035 | |a (DE-599)KXP172718212X | ||
| 035 | |a (OCoLC)1196094054 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DE-101 |
| 100 | 1 | |a Neumann-Haefelin, Elke |d 1976- |e verfasserin |0 (DE-588)124676464 |0 (DE-627)521531853 |0 (DE-576)186527160 |4 aut | |
| 245 | 1 | 0 | |a Subcutaneous enoxaparin safely facilitates bedside sustained low-efficiency hemodialysis in hypercoagulopathic Coronavirus disease 2019 patients - proof-of-principle trial |c Elke Neumann-Haefelin, Eugen Widmeier, Joachim Bansbach, Kai Kaufmann, Sebastian Heinrich, Gerd Walz, Hartmut Bürkle, Johannes Kalbhenn |
| 264 | 1 | |a [Alphen aan den Rijn] |b Wolters Kluwer Health, Inc. |c 2020 | |
| 264 | 2 | |a Freiburg |b Albert-Ludwigs-Universität Freiburg |c 2020 | |
| 300 | |a 1 Online-Ressource (4 Seiten) |b Diagramme | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 650 | 0 | 7 | |0 (DE-588)4042288-4 |0 (DE-627)106215256 |0 (DE-576)209049502 |a Nierenversagen |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)1206347392 |0 (DE-627)1692339907 |a COVID-19 |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4274819-7 |0 (DE-627)104459514 |0 (DE-576)210709855 |a Enoxaparin |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4022808-3 |0 (DE-627)106306901 |0 (DE-576)208945911 |a Hämodialyse |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4024422-2 |0 (DE-627)106298453 |0 (DE-576)208955259 |a Heparin |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4042284-7 |0 (DE-627)104280115 |0 (DE-576)209049499 |a Nierentransplantation |2 gnd |
| 700 | 1 | |a Widmeier, Eugen |d 1982- |e verfasserin |0 (DE-588)1033850845 |0 (DE-627)742689751 |0 (DE-576)381512649 |4 aut | |
| 700 | 1 | |a Bansbach, Joachim |d 1973- |e verfasserin |0 (DE-588)132725991 |0 (DE-627)525920609 |0 (DE-576)262459647 |4 aut | |
| 700 | 1 | |a Kaufmann, Kai Björn |d 1984- |e verfasserin |0 (DE-588)1024324591 |0 (DE-627)719681855 |0 (DE-576)368158810 |4 aut | |
| 700 | 1 | |a Heinrich, Sebastian J. |e verfasserin |0 (DE-588)136810144 |0 (DE-627)587261846 |0 (DE-576)30128623X |4 aut | |
| 700 | 1 | |a Walz, Gerd |d 1957- |e verfasserin |0 (DE-588)111077415X |0 (DE-627)865160295 |0 (DE-576)47577373X |4 aut | |
| 700 | 1 | |a Bürkle, Hartmut |e verfasserin |0 (DE-588)1120525624 |0 (DE-627)873461290 |0 (DE-576)480400652 |4 aut | |
| 700 | 1 | |a Kalbhenn, Johannes |e verfasserin |0 (DE-588)1105505324 |0 (DE-627)862670721 |0 (DE-576)473537702 |4 aut | |
| 773 | 0 | 8 | |i Sonderdruck aus |t Critical care explorations |g 2, 6 (2020), e0155 |x 2639-8028 |
| 856 | 4 | 0 | |u https://nbn-resolving.de/urn:nbn:de:bsz:25-freidok-1663422 |q application/pdf |x Resolving-System |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1097/CCE.0000000000000155 |x Resolving-System |z kostenfrei |
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a ISIL_DE-25 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_2403 | ||
| 912 | |a ISIL_DE-LFER | ||
| 935 | |c so | ||
| 951 | |a BO | ||
| 980 | |2 2003 |1 01 |x DE-25 |b 3740561408 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |k Elektronischer Volltext - Zugang über WWW |y l01 |z 17-08-20 | ||
| 980 | |2 2403 |1 01 |x DE-LFER |b 3757459172 |c 00 |f --%%-- |d --%%-- |e n |j --%%-- |y l01 |z 17-09-20 | ||
| 981 | |2 2003 |1 01 |x DE-25 |r http://nbn-resolving.de/urn:nbn:de:bsz:25-freidok-1663422 | ||
| 981 | |2 2403 |1 01 |x DE-LFER |r https://doi.org/10.1097/CCE.0000000000000155 | ||
| 981 | |2 2403 |1 01 |x DE-LFER |r https://nbn-resolving.de/urn:nbn:de:bsz:25-freidok-1663422 | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 00 |s s |a Anticoagulation | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 01 |s s |a Coronavirus disease 2019 | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 02 |s s |a Enoxaparin | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 03 |s s |a Hemodialysis | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 04 |s s |a Heparin | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 05 |s s |a Renal replacement therapy | ||
| 982 | |2 2003 |1 01 |x DE-25 |8 06 |s s |a Acute kidney injury | ||